Zkusit zdarma
89bio, Inc.

89bio, Inc.

ETNB
Cena:
$ 14.84
0.00 (0.00%)
Valuace
70
Růst
10
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB)

17:30 23-09-2025

NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde ...

ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders

ETNB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 89bio, Inc. Is Fair to Shareholders

7:02 18-09-2025

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t...

Shareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public Shareholders

Shareholder Alert: The Ademi Firm Investigates Whether 89bio, Inc. is Obtaining a Fair Price for its Public Shareholders

3:02 18-09-2025

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating 89bio (Nasdaq: ETNB) for possible breach...

89bio, Inc. (ETNB) Presents At Cantor Global Healthcare Conference 2025 (Transcript)

89bio, Inc. (ETNB) Presents At Cantor Global Healthcare Conference 2025 (Transcript)

10:09 09-09-2025

89bio, Inc. (NASDAQ:ETNB ) Cantor Global Healthcare Conference 2025 September 4, 2025 11:30 AM EDT C...

89bio, Inc. (ETNB) Presents At Citi's Biopharma Back To School Conference Transcript

89bio, Inc. (ETNB) Presents At Citi's Biopharma Back To School Conference Transcript

15:05 03-09-2025

89bio, Inc. (NASDAQ:ETNB ) Citi's Biopharma Back to School Conference September 3, 2025 11:15 AM EDT...

89bio to Participate in Upcoming Investor Conferences

89bio to Participate in Upcoming Investor Conferences

16:05 28-08-2025

SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopha...

89bio: Promising As Pegozafermin Nears Phase 3 Readout

89bio: Promising As Pegozafermin Nears Phase 3 Readout

8:22 11-08-2025

Pegozafermin is ETNB's long-acting FGF21 analog. It's undergoing three Phase 3 trials. Two of those ...

89bio (ETNB) Q2 R&D Jumps 131%

89bio (ETNB) Q2 R&D Jumps 131%

22:38 07-08-2025

89bio (ETNB) Q2 R&D Jumps 131%...

89bio Reports Second Quarter 2025 Financial Results and Corporate Updates

89bio Reports Second Quarter 2025 Financial Results and Corporate Updates

16:05 07-08-2025

– ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 topline histology data expected in 1H 2027 an...

89bio to Participate in Upcoming Investor Conferences

89bio to Participate in Upcoming Investor Conferences

16:05 06-05-2025

SAN FRANCISCO, May 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasd...

89bio Reports First Quarter 2025 Financial Results and Corporate Updates

89bio Reports First Quarter 2025 Financial Results and Corporate Updates

16:05 01-05-2025

– Topline histology data from ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials are expect...

89bio: A Buy With Strong Market Opportunity In MASH And SHTG

89bio: A Buy With Strong Market Opportunity In MASH And SHTG

4:46 18-04-2025

Initiate Buy rating for 89bio, Inc. due to promising lead candidate pegozafermin targeting MASH and ...

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?

10:40 06-03-2025

Here is how 89BIO (ETNB) and Eton Pharmaceuticals, Inc. (ETON) have performed compared to their sect...

89bio price target lowered by $8 at H.C. Wainwright, here's why

89bio price target lowered by $8 at H.C. Wainwright, here's why

11:16 28-02-2025

13 Nov 29 Jan...

89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

16:05 27-02-2025

– ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials in patients with non-cirrhotic (F2-F3)...

Should You Buy 89BIO (ETNB) After Golden Cross?

Should You Buy 89BIO (ETNB) After Golden Cross?

10:55 20-02-2025

89BIO (ETNB) is looking like an interesting pick from a technical perspective, as the company reache...

Wall Street Analysts See a 171.42% Upside in 89BIO (ETNB): Can the Stock Really Move This High?

Wall Street Analysts See a 171.42% Upside in 89BIO (ETNB): Can the Stock Really Move This High?

10:55 20-02-2025

The average of price targets set by Wall Street analysts indicates a potential upside of 171.4% in 8...

Wall Street Analysts Think 89BIO (ETNB) Could Surge 219.06%: Read This Before Placing a Bet

Wall Street Analysts Think 89BIO (ETNB) Could Surge 219.06%: Read This Before Placing a Bet

10:55 03-02-2025

The average of price targets set by Wall Street analysts indicates a potential upside of 219.1% in 8...

89bio's Pegozafermin Is Now Gaining Momentum

89bio's Pegozafermin Is Now Gaining Momentum

6:05 30-01-2025

89bio's Pegozafermin Is Now Gaining Momentum...

89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants

89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants

22:31 28-01-2025

SAN FRANCISCO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinica...

close

89BIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF 89BIO, INC. - ETNB

06-10-2025
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, ...
Více zde

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF 89BIO, INC. (NASDAQ: ETNB)

23-09-2025
NEW YORK , SEPT. 23, 2025 /PRNEWSWIRE/ -- CLASS ACTION ATTORNEY  JUAN MONTEVERDE  WITH MONTEVERDE ...
Více zde

89BIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF 89BIO, INC. - ETNB

19-09-2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde

ETNB STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF 89BIO, INC. IS FAIR TO SHAREHOLDERS

18-09-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

SHAREHOLDER ALERT: THE ADEMI FIRM INVESTIGATES WHETHER 89BIO, INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

18-09-2025
MILWAUKEE--(BUSINESS WIRE)--THE ADEMI FIRM IS INVESTIGATING 89BIO (NASDAQ: ETNB) FOR POSSIBLE BREACH...
Více zde

89BIO, INC. ANNOUNCES AGREEMENT TO BE ACQUIRED BY ROCHE

18-09-2025
– 89BIO STOCKHOLDERS TO RECEIVE UP TO $20.50 PER SHARE IN CASH, COMPRISED OF $14.50 PER SHARE IN C...
Více zde

89BIO ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-09-2025
SAN FRANCISCO, SEPT. 05, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NA...
Více zde

89BIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

28-08-2025
SAN FRANCISCO, AUG. 28, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (NASDAQ: ETNB), A CLINICAL-STAGE BIOPHA...
Více zde

89BIO REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND CORPORATE UPDATES

07-08-2025
– ENLIGHTEN-FIBROSIS AND ENLIGHTEN-CIRRHOSIS PHASE 3 TOPLINE HISTOLOGY DATA EXPECTED IN 1H 2027 AN...
Více zde

89BIO ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

04-08-2025
SAN FRANCISCO, AUG. 04, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NAS...
Více zde

89BIO ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-07-2025
SAN FRANCISCO, JULY 09, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NAS...
Více zde

89BIO ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-06-2025
SAN FRANCISCO, JUNE 06, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NAS...
Více zde

89BIO TO PARTICIPATE IN GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

04-06-2025
SAN FRANCISCO, JUNE 04, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NAS...
Více zde

89BIO ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-05-2025
SAN FRANCISCO, MAY 09, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NASD...
Více zde

89BIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

06-05-2025
SAN FRANCISCO, MAY 06, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NASD...
Více zde

89BIO REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND CORPORATE UPDATES

01-05-2025
– TOPLINE HISTOLOGY DATA FROM ENLIGHTEN-FIBROSIS AND ENLIGHTEN-CIRRHOSIS PHASE 3 TRIALS ARE EXPECT...
Více zde

89BIO TO PARTICIPATE IN THE LEERINK PARTNERS GLOBAL HEALTHCARE CONFERENCE

03-03-2025
SAN FRANCISCO, MARCH 03, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NA...
Více zde

89BIO REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CORPORATE UPDATES

27-02-2025
– ENLIGHTEN-FIBROSIS AND ENLIGHTEN-CIRRHOSIS PHASE 3 TRIALS IN PATIENTS WITH NON-CIRRHOTIC (F2-F3)...
Více zde

89BIO ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-02-2025
SAN FRANCISCO, FEB. 06, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NAS...
Více zde

89BIO, INC. ANNOUNCES PRICING OF $250.0 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

28-01-2025
SAN FRANCISCO, JAN. 28, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (“89BIO”) (NASDAQ: ETNB), A CLINICA...
Více zde

89BIO, INC. ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

27-01-2025
SAN FRANCISCO, JAN. 27, 2025 (GLOBE NEWSWIRE) -- 89BIO, INC. (“89BIO”) (NASDAQ: ETNB), A CLINICA...
Více zde

89BIO ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

19-12-2024
SAN FRANCISCO, DEC. 19, 2024 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NAS...
Více zde

89BIO ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

29-11-2024
SAN FRANCISCO, NOV. 29, 2024 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NAS...
Více zde

89BIO PRESENTS NEW ANALYSES EVALUATING PEGOZAFERMIN AND POTENTIAL BENEFIT OF NON-INVASIVE TESTS FROM THE ENLIVEN PHASE 2B TRIAL IN MASH PATIENTS AT AASLD THE LIVER MEETING® 2024

15-11-2024
NEW POST-HOC ANALYSES REINFORCE PEGOZAFERMIN'S POTENTIAL ANTI-FIBROTIC EFFECTS AND THE POTENTIAL UTI...
Více zde

89BIO, INC. ANNOUNCES UPSIZED PRICING OF $125.0 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

12-11-2024
SAN FRANCISCO, NOV. 12, 2024 (GLOBE NEWSWIRE) -- 89BIO, INC. (“89BIO”) (NASDAQ: ETNB), A CLINICA...
Více zde

89BIO, INC. ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

12-11-2024
SAN FRANCISCO, NOV. 12, 2024 (GLOBE NEWSWIRE) -- 89BIO, INC. (“89BIO”) (NASDAQ: ETNB), A CLINICA...
Více zde

89BIO TO PARTICIPATE IN THE UBS GLOBAL HEALTHCARE CONFERENCE

05-11-2024
SAN FRANCISCO, NOV. 05, 2024 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NAS...
Více zde

89BIO TO PRESENT NEW ANALYSES FROM ENLIVEN PHASE 2B PEGOZAFERMIN TRIAL IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AT AASLD THE LIVER MEETING® 2024

15-10-2024
SAN FRANCISCO, OCT. 15, 2024 (GLOBE NEWSWIRE) -- 89BIO, INC. (NASDAQ: ETNB), A CLINICAL-STAGE BIOPHA...
Více zde

89BIO ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

11-10-2024
SAN FRANCISCO, OCT. 11, 2024 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NAS...
Více zde

89BIO TO PARTICIPATE IN THE H.C. WAINWRIGHT 8TH ANNUAL MASH INVESTOR CONFERENCE

30-09-2024
SAN FRANCISCO, SEPT. 30, 2024 (GLOBE NEWSWIRE) -- 89BIO, INC. (THE “COMPANY” OR “89BIO”) (NA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-10-30 00:00:008-KStáhnout
2025-09-18 01:00:008-KStáhnout
2025-09-18 00:00:008-KStáhnout
2025-08-08 01:00:0010-QStáhnout
2025-08-08 00:00:0010-QStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 00:00:008-KStáhnout
2025-05-30 01:00:008-KStáhnout
2025-05-30 00:00:008-KStáhnout
2025-05-02 01:00:0010-QStáhnout
2025-05-02 00:00:0010-QStáhnout
2025-05-01 01:00:008-KStáhnout
2025-05-01 00:00:008-KStáhnout
2025-04-09 01:00:008-KStáhnout
2025-04-09 00:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2025-02-04 00:00:008-KStáhnout
2025-02-03 23:00:008-KStáhnout
2025-01-29 00:00:008-KStáhnout
2025-01-28 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-12-16 00:00:008-KStáhnout
2024-12-15 23:00:008-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-10-03 01:00:008-KStáhnout
2024-10-03 00:00:008-KStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-05 01:00:008-KStáhnout
2024-08-05 01:00:0010-QStáhnout
2024-08-05 00:00:008-KStáhnout
2024-08-05 00:00:0010-QStáhnout
2024-05-31 01:00:008-KStáhnout
2024-05-31 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-04-17 01:00:008-KStáhnout
2024-04-17 00:00:008-KStáhnout
2024-04-10 01:00:008-KStáhnout
2024-04-10 00:00:008-KStáhnout
2024-03-01 00:00:0010-KStáhnout
2024-02-29 23:00:0010-KStáhnout
2024-02-29 00:00:008-KStáhnout
2024-02-28 23:00:008-KStáhnout
2023-12-08 00:00:008-KStáhnout
2023-12-07 23:00:008-KStáhnout
2023-12-06 00:00:008-KStáhnout
2023-12-05 23:00:008-KStáhnout
2023-12-04 00:00:008-KStáhnout
2023-12-03 23:00:008-KStáhnout
2023-11-27 00:00:008-KStáhnout
2023-11-26 23:00:008-KStáhnout
2023-11-14 00:00:008-KStáhnout
2023-11-13 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-08-15 01:00:008-KStáhnout
2023-08-15 00:00:008-KStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-08 01:00:0010-QStáhnout
2023-05-08 00:00:0010-QStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 00:00:008-KStáhnout
2023-03-28 01:00:008-KStáhnout
2023-03-28 00:00:008-KStáhnout
2023-03-22 00:00:008-KStáhnout
2023-03-21 23:00:008-KStáhnout
2023-03-15 00:00:0010-KStáhnout
2023-03-14 23:00:0010-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-02-16 00:00:008-KStáhnout
2023-02-15 23:00:008-KStáhnout
2023-02-15 00:00:008-KStáhnout
2023-02-14 23:00:008-KStáhnout
2023-01-06 00:00:008-KStáhnout
2023-01-05 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-07-01 01:00:008-KStáhnout
2022-07-01 00:00:008-KStáhnout
2022-06-28 01:00:008-KStáhnout
2022-06-28 00:00:008-KStáhnout
2022-06-07 01:00:008-KStáhnout
2022-06-07 00:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-05-11 01:00:008-KStáhnout
2022-05-11 00:00:008-KStáhnout
2022-03-24 00:00:008-KStáhnout
2022-03-24 00:00:0010-KStáhnout
2022-03-23 23:00:008-KStáhnout
2022-03-23 23:00:0010-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-01-24 00:00:008-KStáhnout
2022-01-23 23:00:008-KStáhnout
2021-11-12 00:00:008-KStáhnout
2021-11-12 00:00:0010-QStáhnout
2021-11-11 23:00:008-KStáhnout
2021-11-11 23:00:0010-QStáhnout
2021-11-03 00:00:008-KStáhnout
2021-11-02 23:00:008-KStáhnout
2021-08-13 01:00:0010-QStáhnout
2021-08-13 00:00:0010-QStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 00:00:008-KStáhnout
2021-07-30 01:00:008-KStáhnout
2021-07-30 00:00:008-KStáhnout
2021-06-10 01:00:008-KStáhnout
2021-06-10 00:00:008-KStáhnout
2021-06-04 01:00:008-KStáhnout
2021-06-04 00:00:008-KStáhnout
2021-05-14 01:00:0010-QStáhnout
2021-05-14 00:00:0010-QStáhnout
2021-05-13 01:00:008-KStáhnout
2021-05-13 00:00:008-KStáhnout
2021-03-25 00:00:0010-KStáhnout
2021-03-24 23:00:0010-KStáhnout
2021-03-24 00:00:008-KStáhnout
2021-03-23 23:00:008-KStáhnout
2020-11-13 00:00:0010-QStáhnout
2020-11-12 23:00:0010-QStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-09 23:00:008-KStáhnout
2020-10-05 01:00:008-KStáhnout
2020-10-05 00:00:008-KStáhnout
2020-09-14 01:00:008-KStáhnout
2020-09-14 00:00:008-KStáhnout
2020-08-13 01:00:0010-QStáhnout
2020-08-13 00:00:0010-QStáhnout
2020-06-26 01:00:008-KStáhnout
2020-06-26 00:00:008-KStáhnout
2020-06-04 01:00:008-KStáhnout
2020-06-04 00:00:008-KStáhnout
2020-05-13 01:00:008-KStáhnout
2020-05-13 01:00:0010-QStáhnout
2020-05-13 00:00:008-KStáhnout
2020-05-13 00:00:0010-QStáhnout
2020-05-04 01:00:008-KStáhnout
2020-05-04 00:00:008-KStáhnout
2020-04-23 01:00:008-KStáhnout
2020-04-23 00:00:008-KStáhnout
2020-04-13 01:00:008-KStáhnout
2020-04-13 00:00:008-KStáhnout
2020-03-26 00:00:008-KStáhnout
2020-03-25 23:00:008-KStáhnout
2020-03-18 00:00:008-KStáhnout
2020-03-18 00:00:0010-KStáhnout
2020-03-17 23:00:008-KStáhnout
2020-03-17 23:00:0010-KStáhnout
2019-12-31 00:00:008-KStáhnout
2019-12-30 23:00:008-KStáhnout
2019-12-18 00:00:008-KStáhnout
2019-12-18 00:00:0010-QStáhnout
2019-12-17 23:00:008-KStáhnout
2019-12-17 23:00:0010-QStáhnout
2019-12-16 00:00:008-KStáhnout
2019-12-15 23:00:008-KStáhnout
2019-11-15 00:00:008-KStáhnout
2019-11-14 23:00:008-KStáhnout
preloader